FDA Fast-Tracks New Alzheimer’s Drug in Boost to Biden’s Reelection Bid
In a critical boost to President Joe Biden’s reelection prospects, the Food and Drug Administration has approved a new Alzheimer’s drug that “may modestly slow the pace of cognitive decline,” according to the New York Times. …